Sign up to save your podcasts
Or
Share Molnupiravir: From Press Release to Practice
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Molnupiravir: From Press Release to Practice
Molnupiravir is a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2 made by Merck that helps COVID patients.
Show Notes: https://eddyjoemd.com/molnupiravir/
Although great care has been taken to ensure that the information in this podcast are accurate, eddyjoe, LLC shall not be held responsible or in any way liable for the continued accuracy of the information, or for any errors, omissions or inaccuracies, or for any consequences arising therefrom.
Website: www.eddyjoemd.com
Instagram: www.instagram.com/eddyjoemd
Twitter: www.twitter.com/eddyjoemd
Facebook: www.facebook.com/eddyjoemd
Podcast: https://anchor.fm/eddyjoemd
My Amazon store for resources you may find helpful: www.amazon.com/shop/eddyjoemd
View all episodes
By Eddy Joe Gutierrez, MD
4.9
193193 ratings
Molnupiravir is a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2 made by Merck that helps COVID patients.
Show Notes: https://eddyjoemd.com/molnupiravir/
Although great care has been taken to ensure that the information in this podcast are accurate, eddyjoe, LLC shall not be held responsible or in any way liable for the continued accuracy of the information, or for any errors, omissions or inaccuracies, or for any consequences arising therefrom.
Website: www.eddyjoemd.com
Instagram: www.instagram.com/eddyjoemd
Twitter: www.twitter.com/eddyjoemd
Facebook: www.facebook.com/eddyjoemd
Podcast: https://anchor.fm/eddyjoemd
My Amazon store for resources you may find helpful: www.amazon.com/shop/eddyjoemd
More shows like Saving Lives Podcast: Critical Care w/eddyjoemd
View all
The Curbsiders Internal Medicine Podcast
3,374 Listeners
Against The Odds
7,792 Listeners
Critical Care Time
270 Listeners